- Home
- OGI vs CYBN Comparison
OGI vs CYBN Comparison
Compare OGI & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGI
- CYBN
- Stock Information
- Founded
- OGI 2013
- CYBN 2019
- Country
- OGI Canada
- CYBN Canada
- Employees
- OGI N/A
- CYBN N/A
- Industry
- OGI Biotechnology: Pharmaceutical Preparations
- CYBN Pharmaceuticals and Biotechnology
- Sector
- OGI Health Care
- CYBN Health Care
- Exchange
- OGI Nasdaq
- CYBN Nasdaq
- Market Cap
- OGI 204.8M
- CYBN 176.0M
- IPO Year
- OGI N/A
- CYBN N/A
- Fundamental
- Price
- OGI $1.43
- CYBN $7.04
- Analyst Decision
- OGI
- CYBN Strong Buy
- Analyst Count
- OGI 0
- CYBN 3
- Target Price
- OGI N/A
- CYBN $85.00
- AVG Volume (30 Days)
- OGI 922.1K
- CYBN 365.5K
- Earning Date
- OGI 08-13-2025
- CYBN 08-13-2025
- Dividend Yield
- OGI N/A
- CYBN N/A
- EPS Growth
- OGI N/A
- CYBN N/A
- EPS
- OGI 0.05
- CYBN N/A
- Revenue
- OGI $164,107,753.00
- CYBN N/A
- Revenue This Year
- OGI $55.39
- CYBN N/A
- Revenue Next Year
- OGI $14.40
- CYBN N/A
- P/E Ratio
- OGI $29.40
- CYBN N/A
- Revenue Growth
- OGI 50.01
- CYBN N/A
- 52 Week Low
- OGI $0.85
- CYBN $4.81
- 52 Week High
- OGI $2.08
- CYBN $13.88
- Technical
- Relative Strength Index (RSI)
- OGI 47.68
- CYBN 40.31
- Support Level
- OGI $1.30
- CYBN $7.22
- Resistance Level
- OGI $1.69
- CYBN $7.75
- Average True Range (ATR)
- OGI 0.08
- CYBN 0.35
- MACD
- OGI 0.01
- CYBN -0.04
- Stochastic Oscillator
- OGI 33.33
- CYBN 5.44
About OGI Organigram Holdings Inc.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.